Congenital Riedel’s lobe of the liver: A case report

2024-1-1

Comparison of the recommendation of ınternational autoimmune hepatitis pathology group 2022 and the simplified criteria for autoimmune hepatitis 2008. A preliminary study

2024-1-1

Molecular Confirmation of Alpha 1-Antitrypsin Deficiency in Liver Transplant Setting: A Province-Wide Experience

2024-1-1

The Pleiotropic Approach to Coronavirus Disease 19 Pathogenesis: The Impact of Liver Diseases Associated Host Genetic Variants

2024-1-1

Response to letter: Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients

2024-1-1

From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkey in terms of metabolic profile and MASLD potential

2024-1-1

Liver disorders in substance abusers

2024-1-1

Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study

2024-1-1

Safety analysis of different intensities of ELF-PEMF in terms of apoptotic, inflammatory and transcription factor NF-κB expression level in rat liver

2024-1-1

Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications

2024-1-1

HBV viral load and tumor and non-tumor factors in patients with HBV-associated HCC

2024-1-1

Comparison of triglyceride-glucose index and anthropometric obesity indices in predicting severe grades of hepatic steatosis in nonalcoholic fatty liver disease among non-diabetic obese individuals

2024-1-1

The preliminary data of gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in Turkish population in HBV related hepatocellular carcinoma

2024-1-1

Risk factors for relapse after discontinuation of tenofovir or entecavir in hepatitis B e Antigen-Negative Patients

2024-1-1

The evolution and revolution of artificial intelligence in hepatology: From current applications to future paradigms

2024-1-1

Phenoconversion and in vivo phenotyping of hepatic cytochrome P450: implications in predictive precision medicine and personalized therapy

2024-1-1

Intrabiliary pressure in the pathophysiology of extra hepatic biliary obstruction

2024-1-1

New classification of Dili in AASLD Guidance: What is next?

2024-1-1

The correlation of ADMA with proinflammatory, liver injury and cancer biomarkers in patients with liver dysfunction

2024-1-1

First two cases of literature: Caustic sclerosing cholangitis due to percutaneous treatment of hydatid liver disease causing liver transplantation

2024-1-1

Transplant and non-transplant HCC patients at a single institution

2024-1-1

Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma

2024-1-1

Early outcome of machine perfusion vs static cold storage of liver graft: A systemic review and meta-analysis of randomized controlled trials

2024-1-1

D-dimer is a prognostic marker for 1-year mortality in patients with chronic liver failure and hepatic encephalopathy

2024-1-1

A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis

2024-1-1

Leflunomide induced fatal dress syndrome need liver transplantation – A case report

2024-1-1

Drug-induced liver injury: Diagnosis, management and the role of liver transplantation

2024-1-1

An alternative method in the diagnosis of intrabiliary lesions: Percutaneous endobiliary brush biopsy

2024-1-1

Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study

2023-6-19

Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients

2023-1-1

First year real life experience with tenofovir alafenamide fumarate: The pythagorean cohort

2023-1-1

Practice patterns and considerations in liver transplantation from living donors with high BMI: A review

2023-1-1

Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye

2023-1-1

The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients

2023-1-1

Comparison of liver resection and living donor liver transplantation in patients with hepatocellular carcinoma within Milan criteria and well-preserved liver function

2023-1-1

Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study

2023-1-1

Prevalence of hepatic steatosis and fibrosis in apparently healthy airline pilots: a transient elastography study

2023-1-1

Evaluation of fibrosis with noninvasive biochemical tests in chronic viral hepatitis B

2023-1-1

The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease

2023-1-1

Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease

2023-1-1

Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan

2023-1-1

Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis

2023-1-1

Bioinformatic Analysis of Genetic Changes CLOCK, BMAL1, CRY1, CRY2, PER1, PER2, PER3 and NPAS2 Proteins in HCC Patients

2023-1-1

A new method for predicting alcohol relapse in patients undergoing liver transplantation for alcohol-related liver failure: Barratt scale

2023-1-1

Fingolimod induced fulminant liver failure requiring liver transplantation: A case report

2023-1-1

Is the Y90-Radioembolization treatment effective on the intermediate-advanced stage of Hepatocellular Carcinoma and What is the Albumin-Bilirubin score's prediction factor for survival?

2023-1-1

A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient

2023-1-1

Role of lower dose hepatitis B immune globulin prophylaxis in liver transplantation: A single center perspective

2023-1-1

The heated debate over NAFLD renaming: An ongoing saga

2023-1-1

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease

2023-1-1